Therapeutic Asset Ratings
1,133 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ketorolac Tromethamine
Pancreatic Neoplasm
Andrew Hendifar, MD
Early P1
C
(33)
ksh01
Neoplasm
TCRx Therapeutics Co.Ltd
Early P1
C
(33)
kt032
Ovarian Cancer
Weijia Fang, MD
Early P1
C
(33)
kt095 car-t
Cancer
The First People's Hospital of Lianyungang
Early P1
C
(33)
Lisinopril
Prostate Cancer
University of Rochester
Early P1
C
(33)
lm103
Neoplasm
Suzhou BlueHorse Therapeutics Co., Ltd.
Early P1
C
(33)
lm303
Neoplasm
Suzhou BlueHorse Therapeutics Co., Ltd.
Early P1
C
(33)
Lvivo-Tavec400 Product
Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Early P1
C
(33)
mb1707
Cancer
Mainline Biosciences, Inc.
Early P1
C
(33)
mb1707
Breast Cancer
Mainline Biosciences, Inc.
Early P1
C
(33)
Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-Til)
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early P1
C
(33)
Milk Polar Lipid-Rich Dairy Powder
Obesity Disorder
University of Connecticut
Early P1
C
(33)
Mitazalimab
Breast Cancer
Jennifer Zhang
Early P1
C
(33)
Montelukast
Colorectal Cancer
University of South Florida
Early P1
C
(33)
Montelukast
Ovarian Cancer
University of South Florida
Early P1
C
(33)
mpt0b640
Cancer
J Ints Bio
Early P1
C
(33)
M-SYMPATHOL
Obesity Disorder
University of Missouri-Columbia
Early P1
C
(33)
NEUROPEPTIDE Y HUMAN
Obesity Disorder
University of Texas Southwestern Medical Center
Early P1
C
(33)
nk510
Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Early P1
C
(33)
nk521 cell
Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Early P1
C
(33)
nk521 cell
Ovarian Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Early P1
C
(33)
nkg2d car t-cells
Acute Myeloid Leukemia
Zhejiang University
Early P1
C
(33)
nkg2d chimeric antigen receptor nk cell
Plasma Cell Myeloma
Changzhou No.2 People's Hospital
Early P1
C
(33)
Noradrenaline
Obesity Disorder
University of Missouri-Columbia
Early P1
C
(33)
Personalized Neoantigen Tumor Vaccine
Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Early P1
C
(33)
Showing 1001 to 1025 of 1,133 assets
Previous
Page 41 of 46
Next